Effect of Iron-fortified Pea Powder on Exercise Performance
NCT ID: NCT04872140
Last Updated: 2022-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2021-05-03
2022-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pea Protein and Muscle Mass During Weight Loss
NCT04123938
Effects of Iron Supplementation on Skeletal Muscle Properties in Females With Suboptimal Iron Storage
NCT07084298
Milk Versus a Pea-based Beverage for Bone and Muscle Health in Young Athletes
NCT05382026
Effect of a Bean Protein-added Supplement on Body Composition in High-performance Adolescent Athletes
NCT05307159
Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults
NCT06231069
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
1. Pea power with high iron bio-availability
2. Regular pea powder
3. Placebo (maltodextrin)
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pea power with high iron bio-availability
Pea powder with low phytate levels to increase iron bio-availability (7mg iron per day)
Low phytate pea powder
Exercise performance with low phytate pea powder
Pea powder
Pea powder with normal phytate levels (7mg iron per day)
Regular pea powder
Exercise performance with regular pea powder
Placebo
Placebo (maltodextrin) powder (0g iron per day)
Placebo (maltodextrin)
Exercise performance with placebo (maltodextrin)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low phytate pea powder
Exercise performance with low phytate pea powder
Regular pea powder
Exercise performance with regular pea powder
Placebo (maltodextrin)
Exercise performance with placebo (maltodextrin)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regularly participate in aerobic endurance training
Exclusion Criteria
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Saskatchewan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phil Chilibeck
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Chilibeck, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Saskatchewan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shaw KA, Chilibeck PD, Lindsay DL, Warkentin TD, Ko J, Zello GA. Low phytic acid pea supplementation as an approach to combating iron deficiency in female runners: A randomized control trial. Nutr Health. 2025 Mar;31(1):293-301. doi: 10.1177/02601060231181605. Epub 2023 Jun 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1207
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.